IMC-R117C

· Immunocore Ltd.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for IMC-R117C, covering 2026-01-28 to 2026-01-28. Get the full timeline:

Most recent: Clinical Trial Update: Phase 1/2 Study of IMC-R117C in Selected Advanced Cancers [Phase 1, Phase 2]